# Therapeutic Drug Monitoring-baSed adalimuMab De-escalatiOn in nOn-infecTious cHronic Uveitis

> **NCT06390436** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Centre Hospitalier Universitaire de Saint Etienne** · enrollment: 320 (estimated)

## Conditions studied

- Uveitis
- Chronic Disease

## Interventions

- **DIAGNOSTIC_TEST:** Blood sample
- **DRUG:** Adalimumab Injection

## Key facts

- **NCT ID:** NCT06390436
- **Lead sponsor:** Centre Hospitalier Universitaire de Saint Etienne
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-06
- **Primary completion:** 2028-05
- **Final completion:** 2029-05
- **Target enrollment:** 320 (ESTIMATED)
- **Last updated:** 2025-07-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06390436

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06390436, "Therapeutic Drug Monitoring-baSed adalimuMab De-escalatiOn in nOn-infecTious cHronic Uveitis". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06390436. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*